News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,968 Results
Type
Article (39982)
Company Profile (273)
Press Release (656713)
Section
Business (205059)
Career Advice (2022)
Deals (35528)
Drug Delivery (95)
Drug Development (81180)
Employer Resources (169)
FDA (16193)
Job Trends (14897)
News (346346)
Policy (32604)
Tag
Academia (2558)
Alliances (49711)
Alzheimer's disease (1323)
Approvals (16179)
Artificial intelligence (209)
Bankruptcy (359)
Best Places to Work (11668)
Biotechnology (192)
Breast cancer (231)
Cancer (1771)
Cardiovascular disease (132)
Career advice (1685)
CAR-T (129)
Cell therapy (370)
Clinical research (65482)
Collaboration (693)
Compensation (379)
COVID-19 (2584)
C-suite (172)
Data (1687)
Diabetes (221)
Diagnostics (6325)
Earnings (85797)
Employer resources (145)
Events (111658)
Executive appointments (586)
FDA (17136)
Funding (621)
Gene therapy (252)
GLP-1 (661)
Government (4376)
Healthcare (18817)
Infectious disease (2702)
Inflammatory bowel disease (128)
Interviews (312)
IPO (16502)
Job creations (3663)
Job search strategy (1434)
Layoffs (446)
Legal (7927)
Lung cancer (258)
Manufacturing (242)
Medical device (13309)
Medtech (13314)
Mergers & acquisitions (19414)
Metabolic disorders (572)
Neuroscience (1743)
NextGen: Class of 2025 (6550)
Non-profit (4489)
Northern California (2177)
Obesity (313)
Opinion (201)
Patents (173)
People (57235)
Phase I (20418)
Phase II (28853)
Phase III (21463)
Pipeline (778)
Postmarket research (2563)
Preclinical (8619)
Radiopharmaceuticals (242)
Rare diseases (330)
Real estate (5945)
Regulatory (22052)
Research institute (2324)
Resumes & cover letters (351)
Southern California (1872)
Startups (3624)
United States (19159)
Vaccines (622)
Weight loss (214)
Date
Today (63)
Last 7 days (822)
Last 30 days (2647)
Last 365 days (34415)
2025 (5306)
2024 (35344)
2023 (40196)
2022 (51308)
2021 (55860)
2020 (54178)
2019 (46667)
2018 (35161)
2017 (32250)
2016 (31662)
2015 (37738)
2014 (31490)
2013 (26547)
2012 (28827)
2011 (29476)
2010 (27562)
Location
Africa (721)
Arizona (211)
Asia (37795)
Australia (6202)
California (4968)
Canada (1746)
China (411)
Colorado (226)
Connecticut (234)
Europe (81128)
Florida (730)
Georgia (172)
Illinois (468)
Indiana (271)
Maryland (758)
Massachusetts (3774)
Michigan (200)
Minnesota (344)
New Jersey (1400)
New York (1417)
North Carolina (856)
Northern California (2177)
Ohio (176)
Pennsylvania (1130)
South America (1098)
Southern California (1872)
Texas (729)
Utah (153)
Washington State (475)
696,968 Results for "pulse biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
February 4, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 24, 2024
·
5 min read
Press Releases
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
January 10, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
December 19, 2024
·
1 min read
Press Releases
Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
February 20, 2025
·
1 min read
Deals
Pulse Biosciences, Inc. Announces Commencement of Rights Offering - June 4, 2024
Pulse Biosciences, Inc. today announced that it has commenced its previously announced rights offering of up to $60,000,000 of units (the “Units,” and each, a “Unit”) at the Initial Price (as defined below).
June 4, 2024
·
7 min read
Business
Pulse Biosciences Enhances Executive Leadership Team
Pulse Biosciences, Inc., a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, announced enhancements to its executive leadership team to support its next pivotal phase of growth.
May 14, 2024
·
7 min read
Press Releases
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
January 13, 2025
·
2 min read
Press Releases
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
December 17, 2024
·
6 min read
Press Releases
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
January 30, 2025
·
4 min read
1 of 69,697
Next